Shanghai Fosun, TPB Capital To Buy Chindex, Take Hospital Chain Private
This article was originally published in PharmAsia News
Executive Summary
Shanghai Fosun Phrmaceutical Group has joined with a private-equity firm to buy Chindex International, a China hospital chain, for $369 million.